Il est encore trop tt pour le dire, mais, chose certaine, de tels traitements imposeraient un fardeau conomique extraordinaire notre systme de sant: au Qubec, o un adulte sur quatre est obse, le cot actuel de ces nouveaux mdicaments (environ 500$ par mois) impliquerait une dpense annuelle de plusieurs centaines de millions de dollars (aux tats-Unis, la situation est encore pire: le cot dun traitement de 72 semaines au tirzepatide (15 mg/semaine) est denviron 17,000 $US, tandis que le traitement de 68 semaines avec le semaglutide (2,4 mg/semaine) est prs de 23,000 $US !)
K., Shenouda, S
Recovery, bodybuilding, cortisol, anxiety, and brain-health claims are mostly indirect, preclinical, or unsupported by strong human trials
Sugary foods and beverages Foods and beverages with added sugar, such as candies, sodas, cakes, and other desserts, tend to be high in empty calories with little-to-no nutritional value

Your immune system requires specific nutrients to function optimally: Protein : Supports antibody production and immune cell function Vitamin C : Acts as an antioxidant and supports white blood cell function Zinc : Essential for immune cell development and function Vitamin D : Modulates immune response B vitamins : Support energy metabolism during increased demands Small, Nutrient-Dense Meals When appetite is minimal, focus on maximizing nutrition in small portions: Protein-Rich Options : Greek yogurt with a drizzle of honey Scrambled eggs (easy to digest) Smooth nut butter on crackers Protein shakes or smoothies Bone broth with shredded chicken Easy-to-Digest Carbohydrates : Plain rice or rice porridge Toast with minimal toppings Applesauce Bananas (also help with potassium if youve been vomiting) Oatmeal made with water or milk Vitamin-Rich Foods : Citrus fruits (if tolerated) Steamed vegetables blended into soup Sweet potato (rich in vitamin A) Berries in smoothies Eating Schedule Strategies Timing Matters : Eat small amounts when you feel least nauseated

However, Novo might have a few tricks up its sleeve, as its experimental obesity drug Amycretin could potentially surpass Wegovy and is set to start phase 3 trials in 2026